Navigating the Global Supply Chain: Your Strategic Guide to a China Drug Import and Export Wholesaler
In an increasingly interconnected pharmaceutical landscape, the role of a reliable China drug import and…
News
Onradivir Tablets Officially Approved by NMPA丨Marking a Major Breakthrough in Influenza Treatment
Guangdong, China — May 22, 2025 丨 The National Medical Products Administration (NMPA) has officially…
Suvemcitug Injection Approval in China丨Brings a New Treatment Option for Platinum-Resistant Ovarian Cancer
On July 3, 2025, Simcere Pharmaceutical Group Limited’s innovative drug subsidiary, Simcere, announced that its…
Global First Dual-Target COVID-19 Drug Olgotrelvir Sodium Capsules Approved by China’s NMPA
Recently, the National Medical Products Administration (NMPA) granted conditional approval for Olgotrelvir Sodium Capsules, a…
Firsekibart Injection Approved by NMPA: A Breakthrough IL-1β Antibody Offering Long-Acting Relief for Acute Gouty Arthritis
The National Medical Products Administration (NMPA) has officially approved Firsekibart Injection, a Class 1 innovative…
How China Ensures the Quality and Safety of Its Exported Pharmaceuticals
With the rapid globalization of China’s pharmaceutical industry, the question of how China ensures the…
Verify Authenticity of Chinese Medicines: A Professional Guide from a Pharmaceutical Wholesaler
For international importers and healthcare distributors, learning how to verify authenticity of Chinese medicines has…
Sebaloxavir Marboxil Tablets Approved by NMPA—Opening a New Era of “Single-Dose Long-Lasting Protection” Against Influenza
Nanjing Zenshine Pharmaceutical Co., Ltd. has announced that its independently developed antiviral drug, Sebaloxavir Marboxil…
Lisaftoclax Tablets: The First Domestic Bcl-2 Inhibitor Approved for CLL/SLL Treatment in China
Suzhou Ascentage Pharma has achieved a significant milestone with the conditional approval of Lisaftoclax Tablets…
Ifupinostat Hydrochloride for Injection Receives Conditional Approval in China, Marking a Breakthrough in r/r DLBCL Treatment
The National Medical Products Administration (NMPA) of China has granted conditional approval for Ifupinostat Hydrochloride…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights